Cancer Genetics Inc (NASDAQ:CGIX)

10.70
Delayed Data
As of 3:59pm ET
 +0.39 / +3.78%
Today’s Change
4.83
Today|||52-Week Range
12.67
+60.18%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Cancer Genetics Inc have a median target of 14.00, with a high estimate of 15.75 and a low estimate of 13.00. The median estimate represents a +30.84% increase from the last price of 10.70.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Cancer Genetics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.51
Sales
$4.5M
Reporting Date
Aug 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -15.91%
 
 
 
 
 
 
Growthannually -13.01%
 
 
 
 
 

Sales

Growthquarterly 2.61%
 
 
 
 
 
 
Growthannually 96.83%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account